查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1534059

全球微生物产品市场

Microbial Products
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 250 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到2030年，全球微生物产品市场预计将达到2,472亿美元

2023年全球微生物产品市场预估为1,932亿美元，预估至2030年将达2,472亿美元，2023-2030年分析期间复合年增长率为3.6%。细菌类产品是本报告分析的细分市场之一，预计复合年增长率为 4.4%，到分析期结束时将达到 1,287 亿美元。分析期内，真菌类产品领域的复合年增长率预计为 3.2%。

美国市场预估526亿美元，中国预期复合年增长率7.0%

预计2023年美国微生物产品市场规模将达526亿美元。中国作为世界第二大经济体，预计2030年市场规模将达520亿美元，2023-2030年分析期间复合年增长率为7.0%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 1.1% 和 2.7%。在欧洲，德国的复合年增长率预计为 1.9%。

全球微生物产品市场－主要趋势与驱动因素总结

微生物产品涵盖细菌、真菌、藻类等微生物产生的多种物质，应用于製药、农业、食品饮料、环境管理等多种产业。在医学上，抗生素、疫苗、酵素等微生物产品在疾病预防和治疗中发挥重要作用。例如，第一种发现的抗生素青霉素是从真菌青霉菌中提取的。其他值得注意的微生物产品包括使用基因工程细菌生产的胰岛素和由真菌代谢物製成并用于降低胆固醇水平的他汀类药物。在农业领域，微生物产品被用作生物肥料和生物农药，以促进植物生长并保护作物免受病虫害。例如，根瘤菌促进豆类固氮，苏力菌(Bt) 产生的毒素可有效对抗害虫。这些化肥和农药的环保替代品由于其永续性和减少的环境影响而越来越受欢迎。

食品和饮料产业也严重依赖微生物产品来生产各种发酵食品和饮料，包括优格、起司、麵包、啤酒和葡萄酒。乳酸菌、酵母菌和曲菌等微生物的发酵可提高这些产品的营养价值、风味和保存期限。此外，淀粉酶、蛋白酶和脂肪酶等微生物酶广泛用于食品加工中，以改善质地、味道和消化率。在环境管理中，微生物产品用于生物修復过程，透过分解石油洩漏、重金属和有机废弃物等污染物来清理污染场地。假单胞菌、黄孢原毛平革菌等微生物有助于分解有害物质，恢復生态平衡。此外，透过可再生物质的微生物发酵生产乙醇和生物柴油等生质燃料是减少对石化燃料的依赖和减少温室气体排放的有前途的解决方案。

微生物产品市场的成长受到多种因素的推动。生物技术和基因工程的进步极大地增强了利用和优化工业应用微生物过程的能力，从而产生更有效率、更具成本效益的生产方法。对永续和环保产品不断增长的需求正在推动微生物解决方案在农业、食品生产和环境管理中的采用。消费者的偏好也转向天然和有机产品，从而推动了微生物食品和农业投入品的市场。此外，抗生素抗药性细菌的增加正在推动源自微生物的新型抗生素和疗法的研究和发展。政府对生物技术和环境永续性研究的措施和资助正在进一步推动市场成长。随着这些趋势的不断发展，由于技术进步、监管支援以及消费者对永续性问题意识的增强，微生物产品市场预计将显着扩大。

受访企业范例（共86家）

  • Ajinomoto Health & Nutrition North America, Inc.
  • bioMerieux SA
  • Genomatica, Inc.
  • GlaxoSmithKline plc
  • JH Biotech, Inc.
  • Kan biosys
  • Koninklijke DSM NV
  • Kyowa Hakko Bio Co., Ltd.
  • Lesaffre Group
  • Merck KGaA
  • Microbial Discovery Group, LLC
  • Novartis AG
  • Pfizer Inc.
  • Sanofi Group
  • Valent BioSciences LLC

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP26682

Global Microbial Products Market to Reach US$247.2 Billion by 2030

The global market for Microbial Products estimated at US$193.2 Billion in the year 2023, is expected to reach US$247.2 Billion by 2030, growing at a CAGR of 3.6% over the analysis period 2023-2030. Bacterial Type Products, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$128.7 Billion by the end of the analysis period. Growth in the Fungi Type Products segment is estimated at 3.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$52.6 Billion While China is Forecast to Grow at 7.0% CAGR

The Microbial Products market in the U.S. is estimated at US$52.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$52.0 Billion by the year 2030 trailing a CAGR of 7.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.1% and 2.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Microbial Products Market - Key Trends and Drivers Summarized

Microbial products encompass a diverse range of substances produced by microorganisms, including bacteria, fungi, and algae, which have applications across various industries such as pharmaceuticals, agriculture, food and beverages, and environmental management. In pharmaceuticals, microbial products such as antibiotics, vaccines, and enzymes play a crucial role in disease prevention and treatment. For instance, penicillin, the first antibiotic discovered, is derived from the Penicillium mold. Other notable microbial products include insulin, which is produced using genetically engineered bacteria, and statins, which are derived from fungal metabolites and used to lower cholesterol levels. In agriculture, microbial products are used as biofertilizers and biopesticides to promote plant growth and protect crops from pests and diseases. Rhizobium bacteria, for example, enhance nitrogen fixation in legumes, while Bacillus thuringiensis (Bt) produces toxins that are effective against insect pests. These environmentally friendly alternatives to chemical fertilizers and pesticides are gaining popularity due to their sustainability and reduced environmental impact.

The food and beverage industry also heavily relies on microbial products for the production of various fermented foods and beverages, such as yogurt, cheese, bread, beer, and wine. Fermentation, driven by microorganisms like Lactobacillus, Saccharomyces, and Aspergillus, enhances the nutritional value, flavor, and shelf life of these products. Moreover, microbial enzymes such as amylases, proteases, and lipases are widely used in food processing to improve texture, taste, and digestibility. In environmental management, microbial products are employed in bioremediation processes to clean up contaminated sites by breaking down pollutants like oil spills, heavy metals, and organic waste. Microorganisms such as Pseudomonas and Phanerochaete chrysosporium are instrumental in degrading toxic substances and restoring ecological balance. Additionally, the production of biofuels, such as ethanol and biodiesel, from microbial fermentation of renewable biomass offers a promising solution to reduce dependency on fossil fuels and mitigate greenhouse gas emissions.

The growth in the microbial products market is driven by several factors. Advances in biotechnology and genetic engineering have significantly enhanced the ability to harness and optimize microbial processes for industrial applications, leading to more efficient and cost-effective production methods. The increasing demand for sustainable and eco-friendly products is propelling the adoption of microbial solutions in agriculture, food production, and environmental management. Consumer preferences are also shifting towards natural and organic products, boosting the market for microbial-based foods and agricultural inputs. Furthermore, the rise in antibiotic-resistant bacteria is driving research and development of novel microbial-derived antibiotics and therapeutics. Government initiatives and funding for research in biotechnology and environmental sustainability are providing further impetus to market growth. As these trends continue to evolve, the microbial products market is poised for substantial expansion, driven by technological advancements, regulatory support, and growing consumer awareness of sustainability issues.

Select Competitors (Total 86 Featured) -

  • Ajinomoto Health & Nutrition North America, Inc.
  • bioMerieux SA
  • Genomatica, Inc.
  • GlaxoSmithKline plc
  • JH Biotech, Inc.
  • Kan biosys
  • Koninklijke DSM N.V.
  • Kyowa Hakko Bio Co., Ltd.
  • Lesaffre Group
  • Merck KGaA
  • Microbial Discovery Group, LLC
  • Novartis AG
  • Pfizer Inc.
  • Sanofi Group
  • Valent BioSciences LLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Microbial Products - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Advances in Biotechnology and Genetic Engineering Propel Market Growth
    • Increasing Demand for Sustainable and Eco-Friendly Products Expands Addressable Market Opportunity
    • Consumer Shift towards Natural and Organic Products Drives Adoption
    • Rise in Antibiotic-Resistant Bacteria Spurs Development of Novel Microbial-Derived Therapeutics
    • Enhanced Production Methods Using Microbial Processes Strengthen Business Case for Microbial Products
    • Growing Use of Biofertilizers and Biopesticides in Agriculture Generates Demand
    • Innovations in Microbial Fermentation Techniques Accelerate Adoption in Food and Beverage Industry
    • Expansion of Bioremediation Applications Throws Spotlight on Environmental Management Solutions
    • Development of Microbial Enzymes for Industrial Applications Drives Market Growth
    • Increasing Production of Biofuels from Microbial Fermentation Expands Market Opportunities
    • Technological Advancements in Microbial Strain Improvement Enhance Product Efficacy
    • Integration of Microbial Products in Waste Management Solutions Expands Addressable Market
    • Enhanced Nutritional Value and Flavor Profiles of Fermented Foods Drives Consumer Adoption
    • Expanding Applications of Microbial Products in Pharmaceuticals Spurs Market Growth
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Microbial Products Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Microbial Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Microbial Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Microbial Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Bacterial Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Bacterial Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Bacterial Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Fungi Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Fungi Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Fungi Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Viral Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Viral Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Viral Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pharmaceuticals Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Pharmaceuticals Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Pharmaceuticals Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Biotechnology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Biotechnology Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Biotechnology Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • JAPAN
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • CHINA
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • EUROPE
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Microbial Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Microbial Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Microbial Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • FRANCE
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • GERMANY
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Microbial Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Microbial Products by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Microbial Products by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • INDIA
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Microbial Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Microbial Products by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Microbial Products by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Microbial Products by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Microbial Products by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Microbial Products by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030
  • AFRICA
    • Microbial Products Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Microbial Products by Type - Bacterial Type, Fungi Type and Viral Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Microbial Products by Type - Percentage Breakdown of Value Sales for Bacterial Type, Fungi Type and Viral Type for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Microbial Products by Application - Pharmaceuticals Application, Diagnostics Application and Biotechnology Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Microbial Products by Application - Percentage Breakdown of Value Sales for Pharmaceuticals Application, Diagnostics Application and Biotechnology Application for the Years 2014, 2024 & 2030

IV. COMPETITION